|
1
|
Maximov VV and Aqeilan RI: Genetic factors
conferring metastasis in osteosarcoma. Future Oncol. 12:1623–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 Suppl 7:vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liebner DA: The indications and efficacy
of conventional chemotherapy in primary and recurrent sarcoma. J
Surg Oncol. 111:622–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fagioli F, Aglietta M, Tienghi A, Ferrari
S, del Prever Brach A, Vassallo E, Palmero A, Biasin E, Bacci G,
Picci P and Madon E: High-dose chemotherapy in the treatment of
relapsed osteosarcoma: An Italian sarcoma group study. J Clin
Oncol. 20:2150–2156. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bacci G, Balladelli A, Palmerini E,
Alberghini M, Pollastri P, Galletti S, Mercuri M and Picci P:
Neoadjuvant chemotherapy for osteosarcoma of the extremities in
preadolescent patients: The Rizzoli Institute experience. J Pediatr
Hematol Oncol. 30:908–912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berindan-Neagoe I and Calin GA: Molecular
pathways: microRNAs, cancer cells, and microenvironment. Clin
Cancer Res. 20:6247–6253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sassen S, Miska EA and Caldas C: MicroRNA:
Implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai W, Jiang H, Yu Y, Xu Y, Zuo W, Wang S
and Su Z: miR-367 regulation of DOC-2/DAB2 interactive protein
promotes proliferation, migration and invasion of osteosarcoma
cells. Biomed Pharmacother. 95:120–128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu F, Wan X, Wang D, Kong Z, Zhang Y,
Huang W, Wang C, Wu H and Li Y: MicroRNA-19a acts as a prognostic
marker and promotes prostate cancer progression via inhibiting
VPS37A expression. Oncotarget. 9:1931–1943. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Jiang Z, Ma N, Wang B, Liu J,
Zhang L and Gu L: MicroRNA-223 Targeting STIM1 inhibits the
biological behavior of breast cancer. Cell Physiol Biochem.
45:856–866. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du B, Wu D, Yang X, Wang T, Shi X, Lv Y,
Zhou Z, Liu Q and Zhang W: The expression and significance of
microRNA in different stages of colorectal cancer. Medicine
(Baltimore). 97:e96352018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Wu Y, Sun Z, Wang R and Ma D:
MicroRNA376a inhibits cell proliferation and invasion in
glioblastoma multiforme by directly targeting specificity protein
1. Mol Med Rep. 17:1583–1590. 2018.PubMed/NCBI
|
|
17
|
Zheng Y, Yin L, Chen H, Yang S, Pan C, Lu
S, Miao M and Jiao B: miR-376a suppresses proliferation and induces
apoptosis in hepatocellular carcinoma. FEBS Lett. 586:2396–2403.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Cong W, Wu G, Ju X, Li Z, Duan X,
Wang X and Gao H: MiR-376a suppresses the proliferation and
invasion of non-small-cell lung cancer by targeting c-Myc. Cell
Biol Int. 42:25–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Qu S, Li S, Wang Y, Li Y, Wang Y,
Wang Z and Li R: Silencing SATB1 inhibits proliferation of human
osteosarcoma U2OS cells. Mol Cell Biochem. 378:39–45. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang H, Su X, Guo L, Zhong L, Li W, Yue
Z, Wang X, Mu Y, Li X, Li R and Wang Z: Silencing SATB1 inhibits
the malignant phenotype and increases sensitivity of human
osteosarcoma U2OS cells to arsenic trioxide. Int J Med Sci.
11:1262–1269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Sun X, Wu J and Li Z: MicroRNA-613
suppresses proliferation, migration and invasion of osteosarcoma by
targeting c-MET. Am J Cancer Res. 6:2869–2879. 2016.PubMed/NCBI
|
|
24
|
Qu Q, Chu X and Wang P: MicroRNA-195-5p
suppresses osteosarcoma cell proliferation and invasion by
suppressing naked cuticle homolog 1. Cell Biol Int. 41:287–295.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ren X, Shen Y, Zheng S, Liu J and Jiang X:
miR-21 predicts poor prognosis in patients with osteosarcoma. Br J
Biomed Sci. 73:158–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Q, Wang C, Hou Z, Wang G, Lv J, Wang
H, Yang J, Zhang Z and Zhang H: Serum microRNA-376 family as
diagnostic and prognostic markers in human gliomas. Cancer Biomark.
19:137–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mo ZH, Wu XD, Li S, Fei BY and Zhang B:
Expression and clinical significance of microRNA-376a in colorectal
cancer. Asian Pac J Cancer Prev. 15:9523–9527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng X, Joosse SA, Muller V, Trillsch F,
Milde-Langosch K, Mahner S, Geffken M, Pantel K and Schwarzenbach
H: Diagnostic and prognostic potential of serum miR-7, miR-16,
miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer
patients. Br J Cancer. 113:1358–1366. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang L, Wei QM, Zhang XW, Sheng Q and Yan
XT: MiR-376a promotion of proliferation and metastases in ovarian
cancer: Potential role as a biomarker. Life Sci. 173:62–67. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng Y, Chen H, Yin M, Ye X, Chen G, Zhou
X, Yin L, Zhang C and Ding B: MiR-376a and histone deacetylation 9
form a regulatory circuitry in hepatocellular carcinoma. Cell
Physiol Biochem. 35:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H,
He J, Han P and Tian D: Upregulation of SATB1 promotes tumor growth
and metastasis in liver cancer. Liver Int. 32:1064–1078. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang
Y, Yang Y, Liu X and Wan X: AT-rich sequence binding protein 1:
Contribution to tumor progression and metastasis of human ovarian
carcinoma. Oncol Lett. 3:865–870. 2012.PubMed/NCBI
|
|
33
|
Lu X, Cheng C, Zhu S, Yang Y, Zheng L,
Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent
prognostic marker for gastric cancer in a Chinese population. Oncol
Rep. 24:981–987. 2010.PubMed/NCBI
|
|
34
|
Mao L, Yang C, Wang J, Li W, Wen R, Chen J
and Zheng J: SATB1 is overexpressed in metastatic prostate cancer
and promotes prostate cancer cell growth and invasion. J Transl
Med. 11:1112013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baba H, Ishikawa T, Mogushi K, Ishiguro M,
Uetake H, Tanaka H and Sugihara K: Identification of SATB1 as a
specific biomarker for lymph node metastasis in colorectal cancer.
Anticancer Res. 36:4069–4076. 2016.PubMed/NCBI
|
